META GC Glucose Control & Weight Loss Support Capsules

META GC is a supplement that helps to balance blood sugar levels, improve metabolic health, and support weight management when combined with a healthy lifestyle. It contains clinically studied ingredients that regulate glucose, increase metabolism, and promote weight loss by reducing cravings. META GC helps to optimize body composition by directing carbohydrates towards muscle, which results in fat loss while preserving muscle mass. It can be used alongside GLP-1 medications and before or after bariatric surgery to help achieve optimal weight loss outcomes.

  • Meta GC supports healthy blood sugar levels, promoting a more efficient metabolism for healthy weight management
  • Helps regulate appetite and curb cravings for a more sustainable weight loss approach
  • Optimizes body composition by directing carbohydrates towards muscle, promoting fat loss while preserving lean muscle mass
  • Chromax®, a clinically studied weight loss ingredient, has a 15x higher absorption rate than other forms of chromium, maximizing effectiveness
  • Whether you’re using GLP-1 medications, considering bariatric surgery, or starting fresh, Meta GC can be seamlessly integrated into your weight loss plan

Dose giornaliera:

  • 1 capsule twice daily, shortly before meals
  • Any pre or post surgical patient.

Formulazione:

  • Proprietary Blend: META GC features a proprietary blend that includes Cissus quadrangularis, Chromax chromium picolinate, and Berberine. These three key ingredients work together to promote effective weight loss and glucose control.*
  • Cissus Quadrangularis: Research has demonstrated that consuming a daily 300 mg dose of Cissus quadrangularis over an eight-week period resulted in obese patients achieving more than an 11% total weight loss, a 13% reduction in waist circumference, and a 24% decrease in body fat. Overweight individuals taking the same dose experienced a fat loss of over 30%.*
  • Chromax Chromium Picolinate: Chromax chromium picolinate can help reduce body fat and preserve lean body mass when used as part of a healthy diet and exercise program.*
  • Berberine: Berberine has been shown to optimize blood sugar and improve insulin sensitivity and body composition.*

IMPORTANTE:

  • In caso di nausea persistente, vomito, disturbi gastrointestinali o altri sintomi, contattare immediatamente il proprio medico curante.
  • Adult Use Only unless recommended by a healthcare provider.
  • Not for use by infants, children, or pregnant or nursing women.
  • Patients should follow the instructions of their physician regarding proper supplementation. Proper supplementation should be viewed as an individualized regimen based on each patient’s individual medical history, laboratory studies, and current medication use.

ATTENZIONE:

  • Keep out of reach of children. If you are pregnant or nursing you should not use this product.

Violet Page Divider

Informazioni supplementari:

  • 400 mcg Chromax®
  • 200 mg GlucoVantage® (berberine)
  • 300 mg CQR-300 (Cissus quadrangularis extract)
  • 200 mg Cinnamon bark powder
  • 10 mg Bioperine (black pepper fruit extract)
  • È importante cercare un prodotto fabbricato in una struttura certificata GMP. Una struttura certificata GMP è una struttura che ha dimostrato di avere buone pratiche di produzione. Si tratta di una certificazione farmaceutica che garantisce che i prodotti siano prodotti e controllati in modo coerente secondo gli standard di qualità.

*Reference

  1. Kuate D, Nash R, Bartholomew B, and Penkova Y. The Use of Cissus quadrangularis (CQR-300) in the Management of Components of Metabolic Syndrome in Overweight and Obese Participants. Natural Products Communications. 2015; (10)7; 1281-1286.
  2. Kaats GR, Blum K, Pullin D, Keith SC, Wood R. A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr Ther Res. 1998; 59(6):379-388. (abstract)
  3. Turner N., Li J. Y., Gosby A., et al. Diabetes. 2008, 57(5):1414-1418.